NeoGenomics’ Pharma Services offer two multiplex immunofluorescence platforms: MultiOmyx™ and PhenoImager™ HT
MultiOmyx™ is a proprietary, high-order multiplexing methodology that enables visualization and characterization of up to 60 proteins in a single FFPE tissue section.
High order ≥ 7 plex
Comprehensive analysis of tumor biology
Deep & precise immuno-profiling
PhenoImager™ HT (formerly Vectra Polaris) is an automated system that allows simultaneous detection of 2-6 different markers from a single FFPE tissue slide which would provide a streamlined workflow for implementing refined low-order multiplex panel sets.
Low order 2-6 plex
High-throughput & faster TAT
Assay transfer & validation
Characterizing CD39 and CD73 cell subtypes in the tumor microenvironment using MultiOmyx immunofluorescence assay
Comprehensive analysis of natural killer cell-associated markers using MultiOmyx immunofluorescence assay
Single-cell immunoprofiling and spatial analysis of hormone receptor subtypes in HER2+ and HER2low breast tumors using multiplexed immunofluorescence
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients